Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

AUG 21, 2014 - Yahoo! News

A Must Read - Share

Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG. Based on favorable results from Phase III trials, Lilly said Thursday it would seek marketing approval in the first half of 2015 for its drug ...

Tags: Lilly psoriasis drug impresses; battle nears with Amgen, Novartis,  Amgen Latest News

AUG 19, 2014 - Yahoo! News

A Must Read - Share

Amgen parathyroid drug succeeds in late-stage trial

(Reuters) - (This story corrects headline and first paragraph in Aug. 18 story to replace "thyroid" with "parathyroid")) Drugmaker Amgen Inc said its experimental drug to reduce parathyroid levels in patients with chronic kidney disease met the main goal in a late-stage trial. The drug, AMG 416, treats hyperparathyroidism, or excessive secretion of parathyroid hormone, in kidney disease patients.

Tags: Amgen parathyroid drug succeeds in late-stage trial,  Amgen Latest News

AUG 19, 2014 - Yahoo! News

A Must Read - Share

Amgen thyroid drug succeeds in late-stage trial

(Reuters) - Drugmaker Amgen Inc said its experimental drug to reduce thyroid levels in patients with chronic kidney disease met the main goal in a late-stage trial. The drug, AMG 416, treats hyperparathyroidism, or excessive secretion of parathyroid hormone, in kidney disease patients. The results follow the recent announcement of positive data from a placebo-controlled late-stage study of AMG 416, ...

Tags: Amgen thyroid drug succeeds in late-stage trial,  Amgen Latest News

AUG 13, 2014 - Wall Street Journal

A Must Read - Share

Amgen Cancer Drug Kyprolis Fails Trial

Amgen Inc. and its subsidiary Onyx Pharmaceuticals said their Kyprolis cancer drug failed to meet its primary endpoint of improving overall survival for patients with relapsed multiple myeloma in a late-stage clinical trial.

Tags: Amgen Cancer Drug Kyprolis Fails Trial,  Amgen Latest News

AUG 13, 2014 - Yahoo! News

A Must Read - Share

Amgen drug fails to improve survival in multiple myeloma trial

(Reuters) - Amgen Inc's Kyprolis drug failed to show it could extend survival compared to standard care for patients with advanced multiple myeloma, a type of blood cancer that develops in the bone marrow. Shares of Amgen were down 2.1 percent at $124.66 in after-hours trading on Wednesday. Amgen said the 315-patient, phase III trial also showed an increase in ...

Tags: Amgen drug fails to improve survival in multiple myeloma trial,  Amgen Latest News